Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
A better diagnosis of rare diabetes to adapt treatment
Diabetes affects more than 400 million people worldwide and is a major public health problem.
Opdivo/Yervoy continues to impress in kidney cancer
Bristol-Myers Squibb has announced that its Opdivo (nivolumab) and Yervoy (ipilimumab) combo has demonstrated superior overall survival, complete response rates and objective response ...
Teva’s Austedo flunks in late-stage paediatric Tourette study
Teva has announced that Austedo (deutetrabenazine) failed to meet its primary endpoints of reduction in motor and phonic tics in moderate-to-severe paediatric Tourette syndrome.
Audentes Therapeutics Announces Plans to Build New State-of-the-Art Gene Therapy Manufacturing Facility in Sanford, North Carolina
SAN FRANCISCO, CA and RALEIGH, N.
Merck Divests Allergopharma to Dermapharm Holding SE
Darmstadt, Germany - Merck, a leading science and technology company, signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding SE (“Dermapharm”).
Scientists ‘strongly condemn’ rumors and conspiracy theories about origin of coronavirus outbreak
A group of 27 prominent public health scientists from outside China is pushing back against a steady stream of stories and even a scientific paper suggesting a laboratory in Wuhan, China, may be the o...
Roche’s Tecentriq bags Priority Review in US
The US Food and Drug Administration (FDA) has accepted Roche’s supplemental Biologics License Application (sBLA), granting Priority Review for Tecentriq (atezolizumab) for ce...
MIT algorithm discovers antibiotic that can fight drug-resistant diseases
A deep learning algorithm developed at MIT has discovered new antibiotics that can treat drug-resistant diseases by killing 35 powerful bacteria.
Medtech conglomerate Medtronic purchases Digital Surgery in bid to expand their Surgical Robotics arm
US medical technology provider Medtronic has announced the acquisition of Digital Surgery, a UK-based company specialising in surgical AI and digital education and training.
Bluebird, cleared for Zynteglo launch, aims to dose first patients soon
Dogged for months by concerns over manufacturing, Bluebird Bio's ultra-pricey flagship gene therapy Zynteglo was finally cleared for launch in Germany just weeks ago.
Joint effort of FDA and India intercepts illegally shipped opioids, cancer drugs
India and the FDA has sometimes had a strained relationship given how often the agency has come down on Indian drugmakers for manufacturing lapses.
Coronavirus: Largest study suggests elderly and sick are most at risk
Health officials in China have published the first details of more than 44,000 cases of Covid-19, in the biggest study since the outbreak began.
323
324
325
326
327
328
329
330
331
